Skip to search formSkip to main contentSkip to account menu

naloxonazine

Known as: Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, ((5alpha)-4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidene)hydrazone, (5alpha)- 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Naloxone
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
In vitro characterization of the effects of endomorphin 1 and 2, endogenous ligands for mu-opioid receptors, on mouse colonic motility.
2003
2003
Antinociception by a peripherally administered novel endomorphin-1 analogue containing beta-proline.
2001
2001
Opioid neurotransmission in the post-ictal analgesia: Involvement of μ1-opioid receptor
Highly Cited
1998
Highly Cited
1998
Homologies and differences in the action of drugs of abuse and a conventional reinforcer (food) on dopamine transmission: an interpretative framework of the mechanism of drug dependence.
Highly Cited
1993
Highly Cited
1993
Central opioid receptor subtype antagonists differentially reduce intake of saccharin and maltose dextrin solutions in rats
1993
1993
The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine
1993
1993
Involvement of mu1 and mu2 opioid receptor subtypes in tail-pinch feeding in rats
Highly Cited
1992
Highly Cited
1992
Central opioid receptor subtype antagonists differentially alter sucrose and deprivation-induced water intake in rats
Highly Cited
1991
Highly Cited
1991
Differential effects of selective opioid peptide antagonists on the acquisition of Pavlovian fear conditioning
Highly Cited
1985
Highly Cited
1985
Involvement of opioid receptor subtypes in rat feeding behavior.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)